Entry Detail



General Information

Database ID:exR0000476
RNA Name:ALDH16A1
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):49453225End Site(bp):49471050
External Links:ENSG00000161618



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
MED22
chr9
133338312
133348131
-
SOX4
chr6
21593751
21598619
+
SLC52A2
chr8
144354135
144361272
+
LARGE2
chr11
45921621
45929096
+
EEF1A1
chr6
73515750
73523797
-
FASTK
chr7
151076593
151080866
-
FAT1
chr4
186587794
186726722
-
LGALS9
chr17
27629798
27649560
+
PPP1R10
chr6
30600413
30618612
-
GRB10
chr7
50590063
50793462
-
ATP6V1G2-DDX39B
chr6
31530219
31546608
-
SLC25A11
chr17
4937130
4940053
-
GSPT1
chr16
11868128
11916082
-
HOXB3
chr17
48548870
48604912
-
THOP1
chr19
2785503
2815807
+
CYB5B
chr16
69424619
69466264
+
ARFGAP1
chr20
63272785
63289790
+
CBX6
chr22
38861422
38872249
-
CTNNA1
chr5
138610967
138935034
+
B3GALT6
chr1
1232237
1235041
+
ADAMTS1
chr21
26835755
26845409
-
DHX36
chr3
154272546
154324487
-
ISG20L2
chr1
156721891
156728799
-
CDC34
chr19
531760
542092
+
ZNRF2
chr7
30284597
30367689
+
BCR
chr22
23179704
23318037
+
EEF2
chr19
3976056
3985463
-
RBM15
chr1
110338506
110346681
+
GPATCH2L
chr14
76151916
76254342
+
DDX39B
chr6
31530219
31542448
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC020928.2
chr19
36773712
36775908
-
AC067852.1
chr17
42536510
42562062
+
AC132217.1
chr11
2129121
2129964
-
VPS9D1-AS1
chr16
89711856
89718165
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.